- Home
- ADAG vs TIMB Comparison
ADAG vs TIMB Comparison
Compare ADAG & TIMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- TIMB
- Stock Information
- Founded
- ADAG 2011
- TIMB 1998
- Country
- ADAG China
- TIMB Brazil
- Employees
- ADAG N/A
- TIMB N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- TIMB Telecommunications Equipment
- Sector
- ADAG Health Care
- TIMB Telecommunications
- Exchange
- ADAG Nasdaq
- TIMB Nasdaq
- Market Cap
- ADAG 110.8M
- TIMB 94.1M
- IPO Year
- ADAG 2021
- TIMB 1998
- Fundamental
- Price
- ADAG $1.79
- TIMB $22.72
- Analyst Decision
- ADAG Strong Buy
- TIMB Hold
- Analyst Count
- ADAG 3
- TIMB 4
- Target Price
- ADAG $7.67
- TIMB $20.50
- AVG Volume (30 Days)
- ADAG 78.0K
- TIMB 308.7K
- Earning Date
- ADAG 08-12-2025
- TIMB 11-03-2025
- Dividend Yield
- ADAG N/A
- TIMB 6.14%
- EPS Growth
- ADAG N/A
- TIMB 16.41
- EPS
- ADAG N/A
- TIMB 0.27
- Revenue
- ADAG $103,204.00
- TIMB $4,779,664,328.00
- Revenue This Year
- ADAG $7,411.34
- TIMB $8.08
- Revenue Next Year
- ADAG $28.29
- TIMB $5.29
- P/E Ratio
- ADAG N/A
- TIMB $16.25
- Revenue Growth
- ADAG N/A
- TIMB 5.32
- 52 Week Low
- ADAG $1.33
- TIMB $11.32
- 52 Week High
- ADAG $3.16
- TIMB $22.90
- Technical
- Relative Strength Index (RSI)
- ADAG 41.71
- TIMB 65.16
- Support Level
- ADAG $1.75
- TIMB $21.74
- Resistance Level
- ADAG $1.95
- TIMB $22.20
- Average True Range (ATR)
- ADAG 0.12
- TIMB 0.39
- MACD
- ADAG -0.01
- TIMB 0.11
- Stochastic Oscillator
- ADAG 20.32
- TIMB 92.97
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About TIMB TIM S.A. (Each representing 5)
TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.